DrugPatentWatch Database Preview
Patents Expiring in 2022
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo | SAXENDA | liraglutide recombinant | SOLUTION;SUBCUTANEOUS | 206321-001 | Dec 23, 2014 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ||||
| Novo Nordisk Inc | LEVEMIR FLEXTOUCH | insulin detemir recombinant | INJECTABLE;SUBCUTANEOUS | 021536-005 | Oct 31, 2013 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ||||
| Novo | RYZODEG 70/30 | insulin aspart; insulin degludec | SOLUTION;SUBCUTANEOUS | 203313-001 | Sep 25, 2015 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ||||
| Novo | XULTOPHY 100/3.6 | insulin degludec; liraglutide | SOLUTION;SUBCUTANEOUS | 208583-001 | Nov 21, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ||||
| Novo | OZEMPIC | semaglutide | SOLUTION;SUBCUTANEOUS | 209637-001 | Dec 5, 2017 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ||||
| Novo | OZEMPIC | semaglutide | SOLUTION;SUBCUTANEOUS | 209637-001 | Dec 5, 2017 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
